Endodermal differentiation of human ES cells
The goals of this proposal are to investigate endodermal differentiation and proliferation in human ES cell cultures. Endodermal cells give rise to the epithelial lining of the respiratory and digestive…
Cell Therapy for Diabetes
Diabetes exacts a tremendous toll on patients, their families, and society in general. Autoimmune Type 1 diabetes, often called juvenile-onset diabetes, is caused by a person’s own immune system mistakenly…
Immune cloaking of human stem cell-derived insulin-producing cells for curative cell therapy without immunosuppression
Research Objective The goal of our project is to generate cells for replacement therapy in patients that have reduced ability to trigger the immune response in the recipient and therefore…
Diabetes: Progress toward stem cell therapies, a Live Google Hangout
California's Stem Cell Agency (CIRM) hosted a live Google Hangout about recent progress in stem cell based strategies for diabetes therapies. The speakers included: Francisco Prieto, MD - CIRM's…
Diabetes: Progress and Promise in Stem Cell Research
CIRM has funded the Diabetes Disease Team led by scientists at ViaCyte, Inc., UCSF, and the La Jolla Institute for Allergy and Immunology. This team aims to bring an embryonic…
Diabetes: Advancing Stem Cell Therapies – 2011 CIRM Grantee Meeting
Eugene Brandon speaks at the 2011 CIRM Grantee Meeting about Viacyte's efforts to develop a stem cell based treatment for diabetes. CIRM has awarded Viacyte $26 million to support their…
Alan Lewis Talks About Getting an Embryonic Stem Cell-Based Therapy to Patients
Embryonic stem cells have the potential to help treat 70 or more diseases, but developing those new therapies will take time. Alan Lewis is the former president and CEO of…
Spotlight on Type 1 Diabetes: Welcoming Remarks
Robert Klein, J.D. gave the welcoming remarks for the "Spotlight on Juvenile Diabetes", an educational event presented at the CIRM Governing Board meeting on September 25, 2008. Klein is Chair…
